SEI INVESTMENTS CO - IMMUNOCORE HLDGS PLC ownership

IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 127 filers reported holding IMMUNOCORE HLDGS PLC in Q3 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.6%.

Quarter-by-quarter ownership
SEI INVESTMENTS CO ownership history of IMMUNOCORE HLDGS PLC
ValueSharesWeighting
Q3 2023$1,463,943
-11.5%
28,207
+2.2%
0.00%0.0%
Q2 2023$1,654,117
-20.1%
27,587
-34.1%
0.00%
-25.0%
Q1 2023$2,069,262
+190.9%
41,854
+235.8%
0.00%
+100.0%
Q4 2022$711,320
-47.2%
12,464
-56.6%
0.00%
-33.3%
Q3 2022$1,348,00028,7230.00%
Other shareholders
IMMUNOCORE HLDGS PLC shareholders Q3 2023
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 576,923$28,523,07325.19%
Velan Capital Investment Management LP 200,000$9,888,0008.43%
RTW INVESTMENTS, LP 5,649,943$279,333,1825.82%
Paradigm Biocapital Advisors LP 1,126,256$55,682,0975.28%
Rock Springs Capital Management LP 3,001,662$148,402,1693.54%
Logos Global Management LP 500,000$24,720,0003.54%
TANG CAPITAL MANAGEMENT LLC 405,600$20,052,8642.99%
GREAT POINT PARTNERS LLC 255,367$12,625,3442.48%
COWEN AND COMPANY, LLC 405,174$20,031,8022.35%
Eschler Asset Management LLP 60,000$2,966,4002.34%
View complete list of IMMUNOCORE HLDGS PLC shareholders